Form 4/A for SOPH SOPHiA GENETICS SA
Accepted 2026-04-08 08:46:40 ET · period of report 2026-04-02 · accession 0001840706-26-000102 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DA | 2026-04-08 08:46 | 2026-04-02 | SOPH | Verma Abhimanyu | CTO | A - Grant | $0.00 | +82.1K | 207.9K | +65% | $0 |
| DA | 2026-04-08 08:46 | 2026-04-02 | SOPH | Verma Abhimanyu | CTO | A - Grant | $0.00 | +119.8K | 119.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-04-02 | A | A | 82,136 | $0.00 | 207,949 | D | — | — | (F1) Represents a restricted stock unit ("RSU") grant made under the Issuer's 2021 Equity Incentive Plan. Each RSU represents a contingent right to receive one ordinary share of the Issuer, subject to the Reporting Person's continued service with the Issuer. 25% of the RSUs will vest on April 2, 2027, and the remaining 75% will vest in equal quarterly installments through April 2, 2030. (F2) This Form 4/A amends the Form 4 filed on April 3, 2026 to correct the amount reported in Column 5 (Amount of Securities Beneficially Owned Following Reported Transaction), which was previously reported as 82,136 ordinary shares due to an inadvertent error. The correct amount is 207,949 ordinary shares. |
| 2 | Derivative | Share Option (Right to Buy) | 2026-04-02 | A | A | 119,760 | $0.00 | 119,760 | D | $5.04 · — to 2036-04-02 | 119,760 Ordinary Shares | (F3) The share option vests and becomes exercisable as to 25% of the ordinary shares on April 2, 2027, and then in equal monthly installments through April 2, 2030. |